Identifying barriers and disparities in the healthcare of patients with alopecia areata: a mixed-methods analysis using claims data and qualitative interview data
The disease burden and frustration of patients with AA is high, mostly caused by limited treatment options and lack of reimbursement, limiting access to approved drugs such as Janus kinase inhibitors.Through the mixed-methods design, we were able to combine patient experiences and quantitative data reflecting the reality of healthcare in Germany.
Authors
- Christine Blome (ORCID: https://orcid.org/0000-0002-1163-1639)
- Kristina Hagenström (ORCID: https://orcid.org/0000-0002-2676-1479)
- Brigitte Stephan (ORCID: https://orcid.org/0000-0001-6127-3692)
- Toni Maria Janke (ORCID: https://orcid.org/0000-0002-9861-9519)
- Theresa Klinger (ORCID: https://orcid.org/0009-0003-0760-3103)
- Katharina Müller (ORCID: https://orcid.org/0009-0004-5797-4014)
- Matthias Augustin (ORCID: https://orcid.org/0000-0001-5128-024X)
- Beke Hester (ORCID: https://orcid.org/0000-0002-1889-4757)
Institutions
- Universität Hamburg (DE)
- University Medical Center Hamburg-Eppendorf (DE)
Publication Details
- Journal
- BMJ Open
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1136/bmjopen-2025-098802
- Citations
- 2
- Primary Topic
- Hair Growth and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 3.67
Funders
- Pfizer